#access-to-medicine
#access-to-medicine

[ follow ]

Merck's Keytruda: A lifesaving drug, a global divide

Keytruda, first approved in 2014, belongs to a class of immunotherapy drugs that enable the immune system to attack cancer cells, extending survival for millions and transforming fatal diagnoses into manageable conditions.

Cancer

Miscellaneous

fromScary Mommy

8 months ago

You Can Now Give Your Family The Nasal Flu Vaccine At Home

Flu vaccination rates are declining due to various barriers, and AstraZeneca's FluMist offers a convenient at-home alternative.

Alternative medicine

fromWIRED

11 months ago

Patients Are Left With Few Options as GLP-1 Copycats Disappear

Access to weight loss medications like Ozempic and Zepbound is uncertain for many as compounded versions exit the market with drug supply stabilization.

UK news

fromwww.independent.co.uk

11 months ago

Brexit costs denying NHS cancer patients life-saving drugs, report warns

Brexit is significantly hindering British cancer patients' access to new treatments and clinical trials.

[ Load more ]

#access-to-medicine#access-to-medicine

Merck's Keytruda: A lifesaving drug, a global divide

You Can Now Give Your Family The Nasal Flu Vaccine At Home

Patients Are Left With Few Options as GLP-1 Copycats Disappear

Brexit costs denying NHS cancer patients life-saving drugs, report warns

#access-to-medicine
#access-to-medicine